Suraksha Diagnostic Limited (NSE:SURAKSHA)
India · Delayed Price · Currency is INR 300.90
-0.05 (-0.02%)
Aug 1, 2025, 3:30 PM IST
Despegar.com Revenue
In the fiscal year ending March 31, 2025, Suraksha Diagnostic had annual revenue of 2.56B INR with 17.02% growth. Suraksha Diagnostic had revenue of 659.12M in the quarter ending March 31, 2025, with 17.35% growth.
Revenue
2.56B
Revenue Growth
+17.02%
P/S Ratio
6.12
Revenue / Employee
2.18M
Employees
1,175
Market Cap
15.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.56B | 372.30M | 17.02% |
| Mar 31, 2024 | 2.19B | 285.75M | 15.03% |
| Mar 31, 2023 | 1.90B | -330.59M | -14.81% |
| Mar 31, 2022 | 2.23B | 831.87M | 59.42% |
| Mar 31, 2021 | 1.40B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Divi's Laboratories | 93.60B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 129.10B |
| Zydus Lifesciences | 232.42B |
| Fortis Healthcare | 77.86B |
| Aurobindo Pharma | 317.24B |